Emerging Technology: Contrast Enhanced Ultrasound Update (2018)

Emerging Technology: Contrast Enhanced Ultrasound Update (2018) is organized by Radiological Society of North America (RSNA) and will be held from Mar 13, 2019 - Mar 12, 2022. This Course has been approved for a maximum of 1.50 AMA PRA Category 1 Credit(s)™.

Description:
Refresher Courses are sessions captured at past RSNA Annual Meetings focusing on themes of health care reform, payment models, research and innovation, patient-centered radiology, and advances in the different imaging modalities. Refresher Courses are targeted to diagnostic, interventional and oncologic radiologists and are designed to improve knowledge and competence in responding to the challenges and advancements in the field of radiology. Most courses include an audio-visual presentation, as well as a corresponding transcript.

Course Learning Objectives:
• Reproduce the contrast-enhanced ultrasound (CEUS) imaging techniques, and the pharmacology of these unique agents.
• Discuss how to start a contrast-enhanced ultrasound service in your practice.
• Summarize how CEUS has been adopted by the ACR LI-RADS as a technique for the definitive diagnosis of HCC.
• Explore how CEUS can enhance ultrasound-guided procedures, and may be used to monitor tumors following ablation.
• Synthesize the major emerging possibilities of microbubble-directed molecular imaging and targeted therapies.
• Recognize ultrasound microbubble agent formulation and pharmacology.
• Discuss the unique imaging techniques required for contrast-enhanced ultrasound (CEUS).
• Explain the ultrasound contrast agent safety profile and contraindications.
• List the steps to start a contrast enhanced ultrasound service from scratch.
• Describe the implementation process at a large academic center.
• Explain CEUS tips and lessons learned from a beginner.
• Summarize CEUS LI-RADS will standardize technique, data collection interpretation and reporting of CEUS exams on patients at risk for HCC.
• Describe differences of CEUS from CT/MRI.
• Develop how to apply new CEUS LIRADS v2017 algorithm with interactive case examples.
• Recognize CEUS features of residual/recurrent tumor following ablative therapies.
• Practice CEUS examinations directed at showing tumor enhancement within or AP-related to the treatment sites.
• Identify the strengths of CEUS for these evaluations related to contrast agent sensitivity and real time dynamic scanning.
• Discuss pre-clinical and translational applications of molecular ultrasound using targeted microbubble contrast agents.